CUBRC 2016-01: Pharmacokinetics / Pharmacodynamics of TP-271 in the Mouse Pneumonia Model with Select Methicillin-Resistant Staphylococcus aureus

StatusFinished
Effective start/end date3/03/1628/02/17

Funding

  • CUBRC, Inc.: $83,047.09

Keywords

  • Infectious Diseases